244 related articles for article (PubMed ID: 1648423)
21. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M; Böswald M; Korn K; Ruder H
Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
[TBL] [Abstract][Full Text] [Related]
24. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
25. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
26. The response to Epstein-Barr virus infection in Sjögren's syndrome.
Venables PJ; Baboonian C; Horsfall AC; Halliday D; Maini RN; Teo CG; Mageed R; Millman G
J Autoimmun; 1989 Aug; 2(4):439-48. PubMed ID: 2551311
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
28. Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes.
Fox RI; Chilton T; Rhodes G; Vaughan JH
J Immunol; 1986 Jul; 137(2):498-501. PubMed ID: 3013992
[TBL] [Abstract][Full Text] [Related]
29. Presence of Epstein-Barr virus DNA in tonsillar tissues.
Brichácek B; Suchánková A; Hirsch I; Síbl O; Rezácova D; Závadová H; Vonka V
Acta Virol; 1981 Nov; 25(6):361-70. PubMed ID: 6120637
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
[TBL] [Abstract][Full Text] [Related]
31. Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome.
Navone R; Lunardi C; Gerli R; Tinazzi E; Peterlana D; Bason C; Corrocher R; Puccetti A
J Autoimmun; 2005 Nov; 25(3):229-34. PubMed ID: 16249071
[TBL] [Abstract][Full Text] [Related]
32. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
33. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
34. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
35. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.
Miller G; Grogan E; Fischer DK; Niederman JC; Schooley RT; Henle W; Lenoir G; Liu CR
N Engl J Med; 1985 Mar; 312(12):750-5. PubMed ID: 2983211
[TBL] [Abstract][Full Text] [Related]
36. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
[TBL] [Abstract][Full Text] [Related]
37. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis.
Inoue N; Harada S; Miyasaka N; Oya A; Yanagi K
J Infect Dis; 1991 Jul; 164(1):22-8. PubMed ID: 1647426
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers.
Oosterveer MA; Markusse HM; Lennette ET; Zou JZ; Bolhuis RL; Gratama JW
J Med Virol; 1993 Dec; 41(4):261-9. PubMed ID: 8106859
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome.
Miyasaka N; Yamaoka K; Tateishi M; Nishioka K; Yamamoto K
J Autoimmun; 1989 Aug; 2(4):427-32. PubMed ID: 2551309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
